Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Straumann® BLC and TLC Implants

K-Number: K230108 · 2023-09-14

Decision Date2023-09-14
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Straumann® BLC and TLC Implants is a medical device manufactured by Institut Straumann AG. It received FDA 510(k) clearance on 2023-09-14 under approval number K230108. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Straumann® BLC and TLC Implants?

Straumann® BLC and TLC Implants is a medical device that received FDA 510(k) clearance on 2023-09-14. It is manufactured by Institut Straumann AG. The 510(k) number is K230108.

When was Straumann® BLC and TLC Implants approved by the FDA?

Straumann® BLC and TLC Implants received FDA 510(k) clearance on 2023-09-14, under approval number K230108.

What company makes Straumann® BLC and TLC Implants?

Straumann® BLC and TLC Implants is manufactured by Institut Straumann AG.

What is the FDA product code for Straumann® BLC and TLC Implants?

The FDA product code for Straumann® BLC and TLC Implants is DZE.

Related Clinical Trials

Other Devices by Institut Straumann AG

View all 56 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.